382 related articles for article (PubMed ID: 10085134)
1. A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling.
Wong L; Deb TB; Thompson SA; Wells A; Johnson GR
J Biol Chem; 1999 Mar; 274(13):8900-9. PubMed ID: 10085134
[TBL] [Abstract][Full Text] [Related]
2. Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation.
Walker F; Kato A; Gonez LJ; Hibbs ML; Pouliot N; Levitzki A; Burgess AW
Mol Cell Biol; 1998 Dec; 18(12):7192-204. PubMed ID: 9819406
[TBL] [Abstract][Full Text] [Related]
3. Involvement of ErbB2 in the signaling pathway leading to cell cycle progression from a truncated epidermal growth factor receptor lacking the C-terminal autophosphorylation sites.
Sasaoka T; Langlois WJ; Bai F; Rose DW; Leitner JW; Decker SJ; Saltiel A; Gill GN; Kobayashi M; Draznin B; Olefsky JM
J Biol Chem; 1996 Apr; 271(14):8338-44. PubMed ID: 8626530
[TBL] [Abstract][Full Text] [Related]
4. An incomplete program of cellular tyrosine phosphorylations induced by kinase-defective epidermal growth factor receptors.
Wright JD; Reuter CW; Weber MJ
J Biol Chem; 1995 May; 270(20):12085-93. PubMed ID: 7538132
[TBL] [Abstract][Full Text] [Related]
5. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
O'Bryan JP; Lambert QT; Der CJ
J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor-receptor mutant lacking the autophosphorylation sites induces phosphorylation of Shc protein and Shc-Grb2/ASH association and retains mitogenic activity.
Gotoh N; Tojo A; Muroya K; Hashimoto Y; Hattori S; Nakamura S; Takenawa T; Yazaki Y; Shibuya M
Proc Natl Acad Sci U S A; 1994 Jan; 91(1):167-71. PubMed ID: 7506413
[TBL] [Abstract][Full Text] [Related]
7. Amphiregulin induces tyrosine phosphorylation of the epidermal growth factor receptor and p185erbB2. Evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cells.
Johnson GR; Kannan B; Shoyab M; Stromberg K
J Biol Chem; 1993 Feb; 268(4):2924-31. PubMed ID: 7679104
[TBL] [Abstract][Full Text] [Related]
8. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4.
Riese DJ; Kim ED; Elenius K; Buckley S; Klagsbrun M; Plowman GD; Stern DF
J Biol Chem; 1996 Aug; 271(33):20047-52. PubMed ID: 8702723
[TBL] [Abstract][Full Text] [Related]
9. Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells.
Shin HS; Lee HJ; Nishida M; Lee MS; Tamura R; Yamashita S; Matsuzawa Y; Lee IK; Koh GY
Circ Res; 2003 Aug; 93(4):302-10. PubMed ID: 12869389
[TBL] [Abstract][Full Text] [Related]
10. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulfate is essential to amphiregulin-induced mitogenic signaling by the epidermal growth factor receptor.
Johnson GR; Wong L
J Biol Chem; 1994 Oct; 269(43):27149-54. PubMed ID: 7929459
[TBL] [Abstract][Full Text] [Related]
12. Heregulin (HRG)-induced mitogenic signaling and cytotoxic activity of a HRG/PE40 ligand toxin in human breast cancer cells.
Fiddes RJ; Janes PW; Sanderson GM; Sivertsen SP; Sutherland RL; Daly RJ
Cell Growth Differ; 1995 Dec; 6(12):1567-77. PubMed ID: 9019162
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor and membrane trafficking. EGF receptor activation of endocytosis requires Rab5a.
Barbieri MA; Roberts RL; Gumusboga A; Highfield H; Alvarez-Dominguez C; Wells A; Stahl PD
J Cell Biol; 2000 Oct; 151(3):539-50. PubMed ID: 11062256
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the receptor binding affinity of amphiregulin by modification of its carboxyl terminal tail.
Adam R; Drummond DR; Solic N; Holt SJ; Sharma RP; Chamberlin SG; Davies DE
Biochim Biophys Acta; 1995 Apr; 1266(1):83-90. PubMed ID: 7718625
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein-2 inhibits MAPK-dependent Elk-1 transactivation and DNA synthesis induced by EGF in mesangial cells.
Ghosh Choudhury G; Jin DC; Kim YSs ; Celeste A; Ghosh-Choudhury N; Abboud HE
Biochem Biophys Res Commun; 1999 May; 258(2):490-6. PubMed ID: 10329414
[TBL] [Abstract][Full Text] [Related]
16. STAT activation by epidermal growth factor (EGF) and amphiregulin. Requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1.
David M; Wong L; Flavell R; Thompson SA; Wells A; Larner AC; Johnson GR
J Biol Chem; 1996 Apr; 271(16):9185-8. PubMed ID: 8621573
[TBL] [Abstract][Full Text] [Related]
17. Transgenic overexpression of amphiregulin induces a mitogenic response selectively in pancreatic duct cells.
Wagner M; Weber CK; Bressau F; Greten FR; Stagge V; Ebert M; Leach SD; Adler G; Schmid RM
Gastroenterology; 2002 Jun; 122(7):1898-912. PubMed ID: 12055597
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF.
Deb TB; Su L; Wong L; Bonvini E; Wells A; David M; Johnson GR
J Biol Chem; 2001 May; 276(18):15554-60. PubMed ID: 11279155
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH
EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptors containing a single tyrosine in their C-terminal tail bind different effector molecules and are signaling-competent.
Gill K; Macdonald-Obermann JL; Pike LJ
J Biol Chem; 2017 Dec; 292(50):20744-20755. PubMed ID: 29074618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
